L 2 4 3 Pill - white rectangle, 18mm
Pill with imprint L 2 4 3 is White, Rectangle and has been identified as Doxycycline Hyclate Delayed-Release 150 mg. It is supplied by Alembic Pharmaceuticals Limited.
Doxycycline is used in the treatment of Actinomycosis; Acne; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L 2 4 3

Doxycycline Hyclate Delayed-Release
- Imprint
- L 2 4 3
- Strength
- 150 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Limited
- National Drug Code (NDC)
- 46708-0483
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
sodium chloride,
povidone k30,
hypromelloses,
talc,
triethyl citrate,
polyethylene glycol 6000,
low substituted hydroxypropyl cellulose,
crospovidone,
silicon dioxide,
corn starch,
hypromellose phthalate,
magnesium stearate,
lactose anhydrous,
lactose monohydrate
Note: Inactive ingredients may vary.
Related images for "L 2 4 3"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,634)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Vibra-Tabs, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.